Theprimary
Published November 7, 2026
Definium LSD formulation cuts anxiety scores across third pivotal trial - Primary
Read the full story at Theprimary
Definium's DT120 LSD formulation cut anxiety scores by 5.1 points versus placebo at 12 weeks in a phase 3 generalized anxiety disorder trial.
Surfaced by this Google Alert
- LSD
